Summary
Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
Publications
Journals
Ciofani JL, Han D, Allahwala UK, et al., 2023, Lipids, Blood Pressure, and Diabetes Mellitus on Risk of Cardiovascular Diseases in East Asians: A Mendelian Randomization Study., Am J Cardiol, Vol:205, Pages:329-337
Gill D, Woolf B, Zagkos L, et al., 2023, The cardiovascular efficacy of lipid-lowering drug targets is not entirely explained by apolipoprotein B reduction: Mendelian randomization evidence, Circulation: Genomic and Precision Medicine, ISSN:2574-8300
Woolf B, Cronjé HT, Zagkos L, et al., 2023, Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization., Bmc Med, Vol:21
Burgess S, Davey Smith G, Davies NM, et al., 2023, Guidelines for performing Mendelian randomization investigations: update for summer 2023, Wellcome Open Research, Vol:4, Pages:186-186
Giontella A, Zagkos L, Geybels M, et al., 2023, Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study., Metabolism, Vol:145